Vivo Ventures LLC, of Palo Alto, Calif., promoted Chen Yu and James Zhao to managing partners...Xceleron Ltd., of York, UK, appointed David Roblin to its board and named Stuart Best senior director of operations...XOMA Ltd., of Berkeley, Calif., appointed Paul Rubin vice president and chief medical officer

Spectrum Pharmaceuticals Inc., of Henderson, Nev., promoted Steven M. Fruchtman to vice president and chief medical officer and Nozar Azarnia to vice president of biostatistics and data management...Tetragenetics Inc., of Cambridge, Mass., appointed Marco Cacciuttolo president and CEO...It also named Ben Machielse and Robert Gailus to its board

Pacira Pharmaceuticals Inc., of Parsippany, N.J., appointed Laura A. Brege and Paul J. Hastings to its board...PolyTherics Ltd., of London, named John Burt CEO and board member after Keith Powell stepped down...Resolve Therapeutics LLC, of Seattle, named Peter Kiener chairman and added Somu Subramaniam as an observer to the board

It also named Patrick Hwu and Mario Sznol to its recently formed scientific and medical advisory board and named Martin Schroeder to its board

Co-founder Douglas P. Clark was named chief medical officer and acting CEO, effective July 1...Compass Biotechnologies Inc., of Edmonton, Alberta, appointed Joseph Sinkule president and chief operating officer...Cytochroma Inc., of Markham, Ontario, appointed Cynthia Lavoie and Osamu Otani to its board

Proteostasis Therapeutics Inc., of Cambridge, Mass., named Alfred Goldberg and Daniel Finley scientific co-founders...It also appointed Suzanne L. Bruhn, Vijay B. Samant and Timothy P. Walbert to its board...Yaupon Therapeutics Inc., of Radnor, Pa., appointed Steve Tullman chairman and CEO

The firm also nominated Stuart Strathdee and Ganesh Kishore to its board...Immune Design Corp., of Seattle, named Carlos V. Paya CEO and board member...Medivation Inc., of San Francisco, appointed Gretchen Burke vice president of finance and business processes

An item in the May 19, 2011, edition of BioWorld Today's Appointments and Advancements column should have said that Adimab LLC appointed Frances Heller to its board

Addex Pharmaceuticals Ltd., of Geneva, added Hoyoung Huh and Oleg Nodelman to its board...Aileron Therapeutics Inc., of Cambridge, Mass., named Julian Adams, Scott Kapnick and John H. McArthur to its board, and named Stephen W. Fesik, Robert H. Grubbs and Michael Hanley to its scientific advisory board

Neoprobe Corp., of Dublin, Ohio, appointed Mark Pykett president and CEO...Regulus Therapeutics Inc., of La Jolla, Calif., named Lars Karlsson vice president of immunology and fibrosis...Tobira Therapeutics Inc., of Manalapan, N.J., named Andrew Hindman president and CEO

Concert Pharmaceuticals Inc., of Lexington, Mass., appointed Mark Roessel vice president of regulatory affairs and quality assurance and named LuAnn Sabounjian vice president of clinical operations...Infinity Pharmaceuticals Inc., of Cambridge, Mass., appointed Joshua D. Hamermesh vice president of business and corporate development...Lightlake Therapeutics Inc., of London, appointed Cynthia McCormick as senior clinical and regulatory advisor

Access Pharmaceuticals Inc., of Dallas, named Anthony Mottola vice president of managed care and market access...Actelion Ltd., of Allschwil, Switzerland, nominated Jean-Pierre Garnier and Robert Bertolini to its board...Ampio Pharmaceuticals Inc., of Greenwood Village, Colo., appointed Mark D. McGregor chief financial officer and corporate secretary

KaloBios Pharmaceuticals Inc., of South San Francisco, added Jonathan Leff as chief medical officer and named Gary A. Lyons to its board...Labopharm Inc., of Laval, Quebec, elected Mark D'Souza president, CEO and board member...Pro-Pharmaceuticals Inc., of Newton, Mass., named Peter G. Traber president and CEO

Hospira Inc., of Lake Forest, Ill., elected F. Michael (Mike) Ball CEO and board member...ITherX Pharmaceuticals Inc., of San Diego, named Stefan Zeuzem chairman of its scientific and clinical advisory board

Addex Pharmaceuticals Ltd., of Geneva, proposed adding Hoyoung Huh and Oleg Nodelman to the board...Codexis Inc., of Redwood City, Calif., named Jacques Beaudry-Losique vice president of corporate development and strategy

Pearl Therapeutics Inc., of Redwood City, Calif., appointed Chuck Bramlage president and CEO...Plethora Solutions Holdings plc, of London, appointed Richard Horsman to its board and named Billy Hargan vice president of commercial operations...Protox Therapeutics Inc., of Vancouver, British Columbia, named William Rohn and Arnit Sobti to its board

ATyr Pharma, of San Diego, formed a therapeutic advisory board comprising Thomas O. Daniel, L. Patrick Gage, Rich Heyman, Keith James, Paul Negulescu, Timothy Rink, Wendell Wierenga and Doug Williams...Otonomy Inc., of San Diego, appointed G. Michael Wall vice president of product development and named Cindy Berejikian vice president of program management

Oncos Therapeutics, of Helsinki, Finland, appointed Jonathan Knowles and Robert Burns to its board...Soligenix Inc., of Princeton, N.J., appointed Kevin Horgan senior vice president and chief medical officer...Topaz Pharmaceuticals Inc., of Horsham, Pa., appointed Mark Strobeck vice president and chief business officer

executive vice president and chief operating officer and named John A. Bellano senior vice president of sales and commercial programs